image
Healthcare - Biotechnology - NASDAQ - US
$ 3.31
-16.7 %
$ 188 M
Market Cap
-4.12
P/E
CASH FLOW STATEMENT
-43.1 M OPERATING CASH FLOW
26.39%
44 M INVESTING CASH FLOW
-16.33%
513 K FINANCING CASH FLOW
-29.14%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Design Therapeutics, Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)202020202021202120222022202320232024202420252025
Net Income -49.6 M
Depreciation & Amortization -5.6 M
Capital Expenditures -340 K
Stock-Based Compensation 13.1 M
Change in Working Capital -993 K
Others 232 K
Free Cash Flow -43.4 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
OPERATING CASH FLOW
Net Income (49.6) (66.9) (63.3) (35.5) (8.3) (2.0)
Depreciation & Amortization (5.6) 0.5 0.4 0.1 5 K 0
Deferred Income Tax 0 0 0 77 K 71 K 0
Stock Based Compensation 13.1 13.1 10.9 4.7 0.5 0
Other Operating Activities 6 K (6.1) (1.3) 19 K 38 K 95 K
Change in Working Capital (1.0) 0.7 2.0 1.4 (0.8) 1.8
Cash From Operations (43.1) (58.6) (51.3) (29.4) (8.7) (0.1)
INVESTING CASH FLOW
Capital Expenditures (0.3) (0.3) (0.9) (1.5) 76 K 0
Other Items 44.3 52.8 (220.1) (52.1) (33.5) 0
Cash From Investing Activities 44.0 52.5 (221.0) (53.6) (33.6) 0
FINANCING CASH FLOW
Common Stock Repurchased 0.5 0.3 0.3 0 0 0
Total Debt Repaid 0 0 0 0 44.5 0.2
Dividends Paid 0 0 0 0 0 0
Other Financing Activities 0.5 0.7 0.2 124.9 1 K 0
Cash From Financing Activities 0.5 0.7 235 0.4 44.5 0.2
CHANGE IN CASH
Net Change In Cash 1.4 (5.3) (272.1) 296.2 2.3 57 K
FREE CASH FLOW
Free Cash Flow (43.4) (58.8) (52.2) (30.9) (8.7) (0.1)